UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 NOTICE OF EFFECTIVENESSEffective Date:May 24, 2023 5:30...
Biocept, Inc. (NASDAQ: BIOC) (“Biocept” or the “Company”), a leading provider of molecular diagnostic assays, products and service, announces the...
Table of Contents As filed with the Securities and Exchange Commission on May 23, 2023...
Biocept, Inc. (Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products and services, announces that as a result of its...
Table of Contents As filed with the Securities and Exchange Commission on May 16, 2023...
Table of Contents As filed with the Securities and Exchange Commission on May 15, 2023...
BIOCEPT INC false 0001044378 0001044378 2023-05-10 2023-05-10 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C...
Biocept, Inc. (Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products and services, reports financial results for the three...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549...
BIOCEPT INC false 0001044378 0001044378 2023-04-17 2023-04-17 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C...
Biocept, Inc. (Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products and services, reports financial results for the 12...
Q30001044378true--12-310001044378us-gaap:ConvertiblePreferredStockMember2022-01-012022-09-300001044378us-gaap:HealthCarePatientServiceMember2022...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.